2016
DOI: 10.1016/j.molliq.2016.03.044
|View full text |Cite
|
Sign up to set email alerts
|

Solubility and thermodynamic functions of deferasirox in different solvents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 30 publications
1
2
0
Order By: Relevance
“…An important reason for such results may be the difference in the wavelength used for spectrophotometric drug quantification as the exact wavelength, and the solvent type used for the calibration curve is not mentioned in the manuscript. The water solubility reported in this work is 0.00373 mg/mL at 25 °C . In our work, the water solubility of this drug is measured to be 0.04 mg/mL at room temperature, which is close to the previously reported DFX aqueous solubility of 0.038 mg/mL at 37 °C…”
Section: Results and Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…An important reason for such results may be the difference in the wavelength used for spectrophotometric drug quantification as the exact wavelength, and the solvent type used for the calibration curve is not mentioned in the manuscript. The water solubility reported in this work is 0.00373 mg/mL at 25 °C . In our work, the water solubility of this drug is measured to be 0.04 mg/mL at room temperature, which is close to the previously reported DFX aqueous solubility of 0.038 mg/mL at 37 °C…”
Section: Results and Discussionsupporting
confidence: 89%
“…Up to now, the solubility of DFX in some monosolvents including methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, acetonitrile, 1,4-dioxane and DMSO, and a binary system of methanol + water has been reported . In order to extend the database on its solubility profile, the aim of this work is to investigate the experimental solubility of this drug in various binary solvent mixtures at 298.2 K.…”
Section: Introductionmentioning
confidence: 99%
“…[20][21][22] DFX is also used in salvage therapy for patients with progressive rhinocerebral mucormycosis. 23 Commercial DFX exhibits poor solubility and slow dissolution rate in water, 24,25 which are major limitations in achieving adequate oral bioavailability for a large percentage of drug compounds in drug development nowadays. Hence, developing various solid forms of DFX and screening them for drug formulation have great signicance.…”
Section: Introductionmentioning
confidence: 99%